Loading
Medicus Pharma Ltd. Stock: price and insider trades · United States
Medicus Pharma Ltd.: what insiders have been doing
This page follows insider dealings at Medicus Pharma Ltd. as filed with SEC (Form 4), a company from the Health Care sector. 19 insiders have disclosed 56 filings since 22 October 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
There has been no open-market purchase by an insider of Medicus Pharma Ltd. for at least a year. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction.
With 56 filings in twelve months, the company is more active than the median of 24 filings across the 3,171 companies we follow on the same exchange. Looking back to 2025, when coverage begins, insiders filed no purchases and 1 sale. For the fiscal year to 31 December 2025, the annual 10-K puts net income at -47.3 m USD.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
62
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€512,883
1 ops. · all time
Who traded when
BuySaleVelocity Fund Partners, LP1 sale
Analyst consensus: bullish or bearish?
Analysts rate Medicus Pharma Ltd. Strong Buy (bullish), based on 4 analysts. Average price target: US$203.75.
Financial data
as of FY 2025FY ended December 2025 · cache
US$2.72
Analyst consensus
4 analystsStrong buy
US$15.00Target US$203.75(+7391%)US$450.00
Income statement
EBITDA-US$34.4M
Net income-US$47.3M0.0% margin
Valuation
PER (forward)-0.1x
P/Book4.9x
Beta-0.30
Balance sheet & cash
Market capUS$3.9M
Total debtUS$5.5M
Free Cash Flow-US$22.8M
Debt / Equity177%
Profitability & ownership
ROE-7446.1%
ROA-110.7%
% insiders15.4%
% institutions2.8%
Last declaration on 16 October 2026
Declarations62 total
2,856,044 sharesCommon SharesTSXSEDI:4792231
514,500 sharesOptionsTSXSEDI:4792224
720,749 sharesCommon SharesTSXSEDI:4792222
122,500 sharesOptionsTSXSEDI:4792215
1,960,000 sharesCommon SharesTSXSEDI:4792213
833,000 sharesOptionsTSXSEDI:4792211
1,441,177 sharesCommon SharesTSXSEDI:4792209
122,500 sharesOptionsTSXSEDI:4792204
161,700 sharesOptionsTSXSEDI:4792197
122,500 sharesOptionsTSXSEDI:4792190
34,727 sharesCommon SharesTSXSEDI:4792182
161,700 sharesOptionsTSXSEDI:4792172
137,200 sharesOptionsTSXSEDI:4792166
161,700 sharesOptionsTSXSEDI:4792164
12,250 sharesCommon SharesTSXSEDI:4792161
23,520 sharesWarrantsTSXSEDI:4792156
338,100 sharesOptionsTSXSEDI:4792152
661,241 sharesCommon SharesTSXSEDI:4792151
781,550 sharesOptionsTSXSEDI:4792135
1,459,704 sharesCommon SharesTSXSEDI:4792126
141,120 sharesWarrantsTSXSEDI:4792120
1,960,000 sharesOptionsTSXSEDI:4792119
777,311 sharesCommon SharesTSXSEDI:4792117
2,882,353 sharesCommon SharesTSXSEDI:4792106
161,700 sharesOptionsTSXSEDI:4792101
25 of 62 declarations
About Medicus Pharma Ltd.
Medicus Pharma Ltd. is a pharmaceutical company focused on developing innovative treatments. It is listed on NASDAQ.
